Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Teva
Boehringer Ingelheim
Baxter
Johnson and Johnson
Fuji
Federal Trade Commission
Merck
Harvard Business School

Generated: June 18, 2018

DrugPatentWatch Database Preview

Watson Labs Teva Company Profile

« Back to Dashboard

What is the competitive landscape for WATSON LABS TEVA, and what generic and branded alternatives to WATSON LABS TEVA drugs are available?

WATSON LABS TEVA has fifty-three approved drugs.

There is one tentative approval on WATSON LABS TEVA drugs.

Summary for Watson Labs Teva
US Patents:0
Tradenames:46
Ingredients:43
NDAs:53

Drugs and US Patents for Watson Labs Teva

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Teva SERTRALINE HYDROCHLORIDE sertraline hydrochloride TABLET;ORAL 077663-002 Feb 6, 2007 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs Teva CARISOPRODOL carisoprodol TABLET;ORAL 086179-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs Teva PROBENECID probenecid TABLET;ORAL 084442-004 Mar 29, 1983 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs Teva IBANDRONATE SODIUM ibandronate sodium TABLET;ORAL 079003-001 Mar 20, 2012 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
McKinsey
AstraZeneca
Accenture
Daiichi Sankyo
Merck
Chubb
Queensland Health
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.